Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study

Philipp Heumann, Juan C. Rosas, Miguel E. Aguado-Barrera, David Azria, Axel Benner, Erik Briers, Renée Bultijnck, Ananya Choudhury, Antonio Gómez-Caamaño, Rudolf Kaaks, Maarten Lambrecht, Tiziana Rancati, Barry S. Rosenstein, Dirk De Ruysscher, Martina E. Schmidt, Susanne Singer, Elena Sperk, Hilary Stobart, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine M. West, Jenny Chang-Claude, Christopher J. Talbot, Tim Rattay, Petra Seibold, Piet Ost, Yolande Lievens, Pieter Deseyne, Fréderic Dupr
British Journal of Cancer · Springer Nature · 2026-11-04 · DOI: 10.1038/s41416-026-03644-2

Abstract

British Journal of Cancer, Published online: 04 November 2026; doi:10.1038/s41416-026-03644-2 Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study

Read at publisher →

Similar articles